MAPS sent a draft of the MDMA/PTSD pilot study that MAPS is seeking to sponsor in Israel to Dr. Moshe Kotler and Dr. Jorge Gleser, Israeli Ministry of Health, for their review. MAPS’ conference on …
The fourth patient in the Spain MDMA/PTSD dose-response study was treated on November 28, 2001. We have now completed the 50 mgs dose group (3 patients received 50 mgs and 1 received a placebo). The next …
Watch it in Quicktime format: 28K (1.9 MB) / 56K (3.7 MB) For clarification of some blatantly misleading information from the MTV show about MDMA causing "holes in the brain" of a heavy MDMA …
Listen / Read the Transcript …
The first patient was treated in the MAPS-supported MDMA/PTSD study being conducted in Madrid, Spain, under the director of José Carlos Bouso, Ph.D. candidate. José Carlos and Marcela Ot’alora …
***Part 1 / Parts 2 & 3***
A pilot study of MDMA therapy in the treatment of PTSD has been approved and will be the first formal therapy study with MDMA ever conducted. (Read current update) MAPS has pledged $54,000 for this study; …
On September 1, 1999, Jordi Camí, MD, PhD, Magi Farré, MD, PhD, and José Carlos Bouso, PhD presented their Phase 1 clinical study of MDMA-assisted psychotherapy for PTSD at the MAPS MDMA …
MAPS organized an international symposium on the medical utility of MDMA. Talks from this event, held August 31 to September 1, 1999, are posted on this site (talks by George Greer, Juraj and Sonja Styk …